Quantcast

Latest Merck & Co. Stories

2014-08-21 12:30:21

DUBLIN, Ireland, August 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" [http://www.researchandmarkets.com/research/3zh3q8/global_hormone ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Hormone replacement therapy, also known as hormone therapy, is a means of replacing...

2014-08-14 16:26:38

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods...

2014-07-23 12:30:34

CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart failure announced adding two industry veterans to its leadership team. Dale Sander has joined as Chief Financial Officer. Dr. Francis Plat will serve in an advisory capacity as Chief Strategy Officer. http://photos.prnewswire.com/prnvar/20131028/DC04442LOGO Mr. Sander has more than 20 years of...

2014-06-23 20:21:23

Agreement to fund development of compounds for cognitive impairment associated with Alzheimer's disease and other conditions of the central nervous system SAN DIEGO, June 23, 2014 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY) announces that it has entered into an exclusive Research Collaboration and License Agreement with Merck, known as MSD outside the United States and Canada, for its BNC375 research program targeting cognitive dysfunction associated with Alzheimer's...

2014-06-10 12:30:30

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insighthttp://www.reportbuyer.com/pharma_healthcare/diseases/non_small_cell_lung_cancer_game_changing_immunotherapies_revolutionise_treatment_kol_insight.html Change is coming to the NSCLC treatment algorithm--and it's coming soon. Revolutionary new immunotherapies, more personalised treatment choices...

2014-06-04 08:34:06

LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Hepatitis Drugs and Vaccines: World Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/therapeutic/hepatitis_drugs_vaccines_world_market_2013_2023.html Report DetailsYour guide to sales outlooks and R&D for hepatitis treatmentsWhere are hepatitis medicines going? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and...

2014-06-02 08:31:38

CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has appointed Roger J. Pomerantz, M.D., F.A.C.P. as its President and Chief Executive Officer. Dr. Pomerantz will also remain as Chairman of the Board of Directors of Seres, where he has served since November of 2013. Dr. Pomerantz brings...

2014-05-15 12:34:27

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibacterial Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/generic_drugs/antibacterial_drugs_world_market_prospects.html Report DetailsDiscover new trends, opportunities and revenue prospects for bacteria-killing medicinesWhere's the antibiotics market heading? How are those products performing? Visiongain's updated report gives you forecasted revenues...

2014-05-06 08:32:51

Move to significantly strengthen position in consumer care LEVERKUSEN, Germany, May 6, 2014 /PRNewswire/ -- Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion). "This acquisition marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business," explained Bayer CEO Dr. Marijn...

2014-04-29 20:27:04

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)http://www.reportbuyer.com/pharma_healthcare/healthcare/market_hospital_acquired_infection_control_sterilization_disinfection_testing_treatment.html Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related